Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 1, 2018 from the Cochrane Infectious Diseases Group (Reviews and protocols published 1 to 31 January).
Three protocols
- LaCourse SM, Cranmer LM, Bekker A, Steingart KR, Black D, Horne DJ, Oren E, Pals S, Modi S, Mathad J. Symptom screening for active tuberculosis in pregnant women living with HIV (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012934. DOI: 10.1002/14651858.CD012934.
- Grace AG, Mittal A, Jain S, Tripathy JP, Satyanarayana S, Tharyan P, Kirubakaran R. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012918. DOI: 10.1002/14651858.CD012918.
Kashangura R, Jullien S, Garner P, Young T, Johnson S. MVA85A vaccine to enhance BCG for preventing tuberculosis (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012915. DOI: 10.1002/14651858.CD012915.
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise.
The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals, particularly malaria, tuberculosis, HIV/AIDS, and neglected tropical diseases. The aims of the CIDG are to impact on policy and research in tropical diseases through the production of high quality and relevant systematic reviews, and to lead developments in review quality improvement and effective dissemination of findings.